Pooled Safety and Efficacy Analysis Examining the Effect of Performance Status on Outcomes in Nine First-Line Treatment Trials Using Individual Data From Patients With Metastatic Colorectal Cancer
SARGENT, Daniel J, KÖHNE, Claus Henning, DOUILLARD, Jean-Yves, STEPHENS, Richard J, GROTHEY, Axel, GOLDBERG, Richard M, SANOFF, Hanna Kelly, BOT, Brian M, SEYMOUR, Matthew T, DE GRAMONT, Aimery, PORSCHEN, Ranier, SALTZ, Leonard B, ROUGIER, Philippe, TOURNIGAND, Christopher
Published in Journal of clinical oncology (20.04.2009)
Published in Journal of clinical oncology (20.04.2009)
Get full text
Journal Article
Managing Older Patients With Colorectal Cancer
Sanoff, Hanna Kelly, Bleiberg, Harry, Goldberg, Richard M
Published in Journal of clinical oncology (10.05.2007)
Published in Journal of clinical oncology (10.05.2007)
Get full text
Journal Article
Comparing FOLFOX delivery in trial and real-world populations using longitudinal cumulative dose
Webster-Clark, Michael, Sanoff, Hanna Kelly, Keil, Alexander P., Sturmer, Til, Westreich, Daniel, Lund, Jennifer Leigh
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Using randomized trial data to estimate effects of complex treatment regimens in real-world patients
Webster-Clark, Michael, Sanoff, Hanna Kelly, Lund, Jennifer Leigh, Sturmer, Til, Westreich, Daniel, Keil, Alexander P.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Comparative effectiveness of trimodal therapy versus definitive chemoradiation in older adults with locally advanced esophageal cancer
Gaber, Charles, Shaheen, Nicholas J., Edwards, Jessie K., Sandler, Robert S, Nichols, Hazel, Sanoff, Hanna Kelly, Lund, Jennifer Leigh
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
A study of pembrolizumab (pembro) in combination with Y90 radioembolization in patients (pts) with poor prognosis hepatocellular carcinoma (HCC) with preserved liver function
McRee, Autumn Jackson, Helft, Paul R., Harris, William Proctor, Sanoff, Hanna Kelly, Johnson, Matthew, Yu, Menggang, O'Neil, Bert
Published in Journal of clinical oncology (01.02.2022)
Published in Journal of clinical oncology (01.02.2022)
Get full text
Journal Article
Longitudinal cumulative dose: A novel measure to assess multiple dimensions of chemotherapy adherence over time
Webster-Clark, Michael, Keil, Alexander P, Sanoff, Hanna Kelly, Sturmer, Til, Westreich, Daniel, Lund, Jennifer Leigh
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Effectiveness of adjuvant FOLFOX versus 5FU for colon cancer treatment in community oncology practice using a hybrid study approach
Lund, Jennifer Leigh, Webster-Clark, Michael, Keil, Alexander P, Westreich, Daniel, Sturmer, Til, Sanoff, Hanna Kelly
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
A study of pembrolizumab (pembro) in combination with Y90 radioembolization in patients (pts) with poor prognosis hepatocellular carcinoma (HCC)
Somasundaram, Ashwin, Helft, Paul R., Harris, William Proctor, Sanoff, Hanna Kelly, Johnson, Guy E., Yu, Menggang, Johnson, Matthew, O'Neil, Bert, McRee, Autumn Jackson
Published in Journal of clinical oncology (01.02.2023)
Published in Journal of clinical oncology (01.02.2023)
Get full text
Journal Article
Building a population management informatics infrastructure for oncology care
Lafata, Jennifer Elston, Harris, Stephen, Fasold, Megan, Holdren, Audrey, Sanoff, Hanna Kelly
Published in Journal of clinical oncology (20.09.2019)
Published in Journal of clinical oncology (20.09.2019)
Get full text
Journal Article
Impact of brain metastases on end-of-life health care utilization
Ray, Emily Miller, Dunham, Lisette, Reeder-Hayes, Katherine Elizabeth, Sanoff, Hanna Kelly
Published in Journal of clinical oncology (20.09.2019)
Published in Journal of clinical oncology (20.09.2019)
Get full text
Journal Article
Phase II single-arm study of palbociclib and cetuximab rechallenge in KRAS/NRAS/BRAF wild-type ( KRAS WT) metastatic colorectal cancer (mCRC) patients (pts)
Sorah, Jonathan D, Moore, Dominic T., Reilley, Matthew, Salem, Mohamed E., Sanoff, Hanna Kelly, Triglianos, Tammy, McRee, Autumn Jackson, Lee, Michael Sangmin
Published in Journal of clinical oncology (01.02.2022)
Published in Journal of clinical oncology (01.02.2022)
Get full text
Journal Article
NRG-GI004/SWOG-S1610: Colorectal cancer metastatic dMMR immuno-therapy (COMMIT) study—A randomized phase III study of atezolizumab (atezo) monotherapyversus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients with deficient DNA mismatch repair (dMMR) or microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC)
Rocha Lima, Caio Max Sao Pedro, Yothers, Greg, Puhalla, Shannon L., Sanoff, Hanna Kelly, Cohen, Deirdre J., Guthrie, Katherine A, Henry, Norah Lynn, Ganz, Patricia A., Kopetz, Scott, Lucas, Peter C., Blanke, Charles D., Jacobs, Samuel A., Hong, Theodore S., Wolmark, Norman, Hochster, Howard S., George, Thomas J., Overman, Michael J.
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Phase II study of ipilimumab, nivolumab, and panitumumab in patients with KRAS / NRAS / BRAF wild-type (WT) microsatellite stable (MSS) metastatic colorectal cancer (mCRC)
Lee, Michael Sangmin, Loehrer, Patrick J., Imanirad, Iman, Cohen, Stacey, Ciombor, Kristen Keon, Moore, Dominic T., Carlson, Cheryl Ann, Sanoff, Hanna Kelly, McRee, Autumn Jackson
Published in Journal of clinical oncology (20.01.2021)
Published in Journal of clinical oncology (20.01.2021)
Get full text
Journal Article
Colorectal cancer metastatic dMMR immuno-therapy (COMMIT) study: A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC)—NRG-GI004/SWOG-S1610
Overman, Michael J., Yothers, Greg, Jacobs, Samuel A., Sanoff, Hanna Kelly, Cohen, Deirdre J., Guthrie, Katherine A, Henry, Norah Lynn, Ganz, Patricia A., Kopetz, Scott, Lucas, Peter C., Blanke, Charles D., Hong, Theodore S., Wolmark, Norman, Hochster, Howard S., George, Thomas J., Rocha Lima, Caio Max Sao Pedro
Published in Journal of clinical oncology (20.01.2024)
Published in Journal of clinical oncology (20.01.2024)
Get full text
Journal Article